-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/wireless-motility-capsule-future_research.pdf
May 01, 2013 - markers
Adults with
suspected
gastroparesis
Populations
Motility Assessment
• Transit time … A major outcome of interest to clinicians is the ability to characterize transit time and to
diagnose … (CTT)
and Total transit time (TTT)
by using the SmartPill
device. … Study design:
Observational Model: Case
Control
Time Perspective:
Prospective
Condition(s): … , combined
small and large bowel
transit time and total transit
time.
-
effectivehealthcare.ahrq.gov/sites/default/files/cf_deliberativemethodswebinar_recruiting.pdf
May 29, 2025 - Decisions
• Incentives
– To have less advantaged represented, you
need to compensate them for their time
-
effectivehealthcare.ahrq.gov/sites/default/files/product/pdf/methods-guide-inclusion-nonrandomized-studies.pdf
September 01, 2022 - Inclusion of NRSIs will increase the scope, time, and resources needed to
complete SRs, and NRSIs pose … Presence of follow-up over time (yes [i.e., longitudinal] vs. no [i.e., cross-sectional])
5. … The first difference (within-group) controls for time-invariant differences within
the intervention … Use of interrupted
time series analysis in evaluating health
care quality improvements. … Reducing warfarin medication interactions:
an interrupted time series evaluation.
-
effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/pdf/methods-guide-inclusion-nonrandomized-studies.pdf
September 01, 2022 - Inclusion of NRSIs will increase the scope, time, and resources needed to
complete SRs, and NRSIs pose … Presence of follow-up over time (yes [i.e., longitudinal] vs. no [i.e., cross-sectional])
5. … The first difference (within-group) controls for time-invariant differences within
the intervention … Use of interrupted
time series analysis in evaluating health
care quality improvements. … Reducing warfarin medication interactions:
an interrupted time series evaluation.
-
effectivehealthcare.ahrq.gov/sites/default/files/topic-refinement.ppt
March 01, 2010 - Thus, the time, effort, and expense to find all of the trials and studies conducted on aliskerin, to … What is the followup time? Finally, S is for setting. What are the settings of interest? … the team reads the topic development documents, they need to do additional background reading from time … to time.
-
effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/pdf/epc-march-2023-grand-rounds-slides.pdf
January 01, 2023 - access for many patients, provides patient and
provider flexibility, is more efficient in terms of time … and/or distance; many possible
• Modes (asynchronous, real-time video, and many others)
• Functions … incorporate it into
work tasks
• Available resources including money, training, physical space, time … frequently mentioned as barriers
• Available resources including money, training, physical space, time … chat to complete an evaluation survey
Upcoming EPC Grand Rounds theme:
Maternal Health
A date and time
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/behavioral-health-screening-disposition-comments.pdf
April 09, 2025 - However, it is not clear why quality-improvement
studies that do not include interrupted-time series … We excluded QI
studies if they did not have a control group
or an interrupted time series. … trends without a time series analysis. … Thank you for your time and consideration.
We agree with your statement. … The time range considered in this draft report excludes some relevant
recent studies.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/treatment-outcomes-chronic-kidney-rapid-research.pdf
November 01, 2024 - Kidney function
o eGFR
o creatinine clearance
o Albumin
o Blood Urea Nitrogen (BUN)
• Increase time … All of the systematic reviews were published in the time period 2019 - 2024. … The
primary studies were published in the time frame 2014–2023. … all high quality)
Author Year;
Country;
Funding Source;
CKD Stage
Quality
Design;
Total N;
Time … to major
CV event, time to a coronary event, time to CVD, coronary artery disease, cerebrovascular
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/ear-infection_executive.pdf
May 01, 2013 - in the recent reviews but were not the
focus of those reviews, observational studies done at any
time … Evidence was insufficient for drawing
10
conclusions regarding improvements in OME at longer
time … We did not limit the time frame for
followup but were most interested in outcomes 3 months
or more … number of children with OME in the
short term relative to watchful waiting, less is known
about its long-term … effects particularly with respect to
functional outcomes.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/treatment-outcomes-diabetes-rapid-research.pdf
November 01, 2024 - Follow-up time: minimum duration of 3 months. … The primary studies were published in the time frame 2017–
2024. … All of the SRs were published in the time period 2017–2023. … Furthermore, many studies had relatively short follow-up periods, which may not fully
capture the long-term … effects of periodontal therapy on diabetic outcomes.
-
effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/data-repository-reviews-charter-140305.pdf
June 01, 2012 - Impetus
− Performing systematic reviews (SRs) is costly in
time, labor, and
money.
− There is … − Meetings will be scheduled at a time when the majority of board members are
anticipated to
be … members not present at meetings will have the opportunity to vote via email
within a specified time … also initiate
email discussions and
will allow
members to vote via
email within a specified time
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/angina-heart-attack-treatments_executive.pdf
January 01, 2014 - admission but
prior to cardiac catheterization or periprocedural if the
agent is initiated at the time … (Note that “upstream” and “pretreatment” refer
to the time before the PCI is begun; “deferred treatment … ”
refers to medications given at the same time as the PCI.) … These studies confirmed that in patients pretreated with
clopidogrel, the use of bivalirudin at the time … In patients
treated with clopidogrel at the time of PCI there was less
major bleeding at 30 days with
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/patient-monitoring-systems-rapid-review.pdf
December 01, 2024 - What resources (e.g., cost, staff, time) are required for implementation?
4. … Study time periods are not defined. … Effect of a Real-Time Electronic Dashboard
on a Rapid Response System. … alerts”[tiab] OR “real time alert”[tiab] OR predict
[tiab]
2. … alerts”:ti,ab OR “real time alert”:ti,ab OR predict:ti,ab
2.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/patient-monitoring-systems-appendix-c.xlsx
January 01, 2024 - The implementation of a real time early warning system using machine learning in an Australian hospital … Real-Time Machine Learning Alerts to Prevent Escalation of Care: A Nonrandomized Clustered Pragmatic … Time to antibiotic administration in case of sepsis was narratively reported. … Changes in variables over time were also incorporated into the clinical comment. … Changes in variables over time were also incorporated into the clinical comment.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-195-disposition-comments-uterine-fibroids.pdf
December 14, 2017 - TEP Reviewer#5 Executive
Summary
Results: Please specify the time period (or range of time
periods … TEP Reviewer#5 Executive
Summary
Results: Again, a time period (or range of time periods) needed … We have added the time frame. … Studies typically did not report emergence over time. … Was the time to death changed by morcellation approach?
-
effectivehealthcare.ahrq.gov/sites/default/files/pulmonary-horizon-scan-high-impact-1312.pdf
December 01, 2013 - (SB-PACT) program for
management of asthma in school children
No high-impact potential at this
time … for inclusion in this report; however, they were deemed
to have no high-impact potential at this time … At the
time experts offered their opinions, the annual ivacaftor cost was estimated at $294,000. … Patients
treated with the drug were reported to have a longer median time to the first exacerbation … The median time
to first exacerbation was 266 days (95% confidence interval [CI], 227 to 313) among
-
effectivehealthcare.ahrq.gov/sites/default/files/communicating_risk_vulnerable_populations_kreps.ppt
May 29, 2025 - populations
Close, familiar, & easily accessible
Easy to use
Dramatic and memorable
Accessible over time
-
effectivehealthcare.ahrq.gov/sites/default/files/product/pdf/deficit-hyperactivity-protocol.pdf
November 01, 2021 - Stimulation59-61 and the FDA-approved external
Trigeminal Nerve Stimulator.62-64
Monitoring and Long-Term … searches, we still do not expect to identify a
substantial amount of data for monitoring strategies and long-term … Finally, no comparator is needed anymore for studies
reporting on long-term effects, and these studies … meta-analyses in the
prior report for cumulative meta-analyses
• KQ 3: Monitoring strategies and long-term … Long-Term Effects of Stimulant Treatment for
ADHD: What Can We Tell Our Patients?
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cancer-ovarian-contraceptives_executive.pdf
June 01, 2013 - that effective screening strategies may not
be possible outside of high-risk populations
because the time … relationship between duration of use and
breast cancer risk, but risk significantly decreased with time … factors, such as duration of
use or time since last use. … There was inconsistent reporting of how variables, such
as time since last use, duration of use, or … Predictions of the long-term
effects of OC use are necessarily based on population-
based, age-specific
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/dcis-endocrine-therapy_research.pdf
August 01, 2012 - At all time
points, use was higher for early invasive
breast cancer, but declines were also greater … We divided women into five
groups characterized by the amount of
time elapsed between their cancer … Tamoxifen use decreased slightly over time, while use of
AIs was relatively stable (Figure 1). … Use of tamoxifen increased slightly as time
from diagnosis increased, while use of AIs
declined. … That
is, different women are included in each
of the five time groups.